Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations; Withdrawal

---
identifier: "/us/fr/2012-15713"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations; Withdrawal"
title_number: 0
title_name: "Federal Register"
section_number: "2012-15713"
section_name: "Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations; Withdrawal"
positive_law: false
currency: "2012-06-27"
last_updated: "2012-06-27"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "2012-15713"
document_type: "rule"
publication_date: "2012-06-27"
agencies:
  - "Health and Human Services Department"
  - "Food and Drug Administration"
cfr_references:
  - "21 CFR Part 20"
fr_citation: "77 FR 38173"
fr_volume: 77
docket_ids:
  - "Docket No. FDA-2012-N-0205"
effective_date: "2012-06-27"
fr_action: "Direct final rule; withdrawal."
---


#  Agreements and Memoranda of Understanding Between the Food and Drug Administration and Other Departments, Agencies, and Organizations; Withdrawal

**AGENCY:**

Food and Drug Administration, HHS.

**ACTION:**

Direct final rule; withdrawal.

**SUMMARY:**

The Food and Drug Administration (FDA) published in the *Federal Register* of March 23, 2012 (77 FR 16923), a direct final rule making technical changes to update a requirement that many of its written agreements and memoranda of understanding with other departments, Agencies, and organizations be published in the *Federal Register.* The comment period closed June 6, 2012. FDA is withdrawing the direct final rule because the Agency received significant adverse comment.

**DATES:**

The direct final rule published at 77 FR 16923, March 23, 2012, is withdrawn, effective June 27, 2012.

**FOR FURTHER INFORMATION CONTACT:**

Daniel W. Sigelman, Office of the Commissioner, Food and Drug Administration, 10903 New Hampshire Ave., Silver Spring, MD 20993-0002, 301-796-4706, FAX: 301-847-8616, email: *[email protected].*

**Authority:**

Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs, the direct final rule published in the *Federal Register* on March 23, 2012 (77 FR 16923) is withdrawn.

Dated: June 22, 2012.

Leslie Kux,

Assistant Commissioner for Policy.